Igalmi Sublingual Film Approved for Agitation With Schizophrenia, Bipolar Disorder
The Food and Drug Administration (FDA) has approved Igalmi (dexmedetomidine) sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. Igalmi is an orally dissolving thin…